"Take out the cash & the company is only valued @ $17M here."
It's actually a great position to be standing in @ $17M with -
Pat-SM6 - multiple melanoma
FDA - Orphan Status
EMA - Orphan status
Phase I/IIa data meeting all end points succesfully
ONYX / AMGEN funding combination trial
Macquarie University using material to develop highly sensitive MM diagnostic test kits < < that's potentially another big kicker with the double hit.
PAT-SM6 - melanoma
Phase I complete
PST-SC1 -
out-license prepped for completed Phase II ovarian cancer
PAT-LM1 -
blood malignancies, solid tumours - lung, pancreas, colon, leukaemias
advanced pre-clinical & set to enter clinic 2014 ?
PAT-SM3 / PAT-NM1 -
preclinical
Find me another company that beats it at $27M with $10M CiB
- Forums
- ASX - By Stock
- $5.5m raised from rights issue
"Take out the cash & the company is only valued @ $17M...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4291214 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 600160 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4291214 | 0.006 |
13 | 4849991 | 0.005 |
12 | 7264199 | 0.004 |
6 | 6065682 | 0.003 |
2 | 2770000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 600160 | 2 |
0.008 | 2092233 | 5 |
0.010 | 126000 | 2 |
0.011 | 680000 | 2 |
0.012 | 292407 | 2 |
Last trade - 16.12pm 09/09/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable